Azad, Md. Abul KalamZiad, Ahmed2021-12-062021-12-0620212021-02ID 16346038http://hdl.handle.net/10361/15699Cataloged from PDF version of thesis report.Includes bibliographical references (pages 66-83).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.An unprecedented emerge of a rapid human-to-human transmissible respiratory illness, known as COVID-19 caused by the SARS-CoV-2, a novel coronavirus from December 2019, in Wuhan, China has changed the world drastically. Soon after its emergence the virus caused a serious health emergency that compelled the health officials to declare it an epidemic, followed by a global pandemic by the World Health Organization (WHO). In spite of some drug’s improving results for treating the symptoms of COVID-19, it has been however recommended that only an effective vaccine can help get rid of this pandemic. In response to this pandemic an unbelievable effort has been observed to develop a vaccine due to the strong coordination and cooperation among the stakeholders, funders, vaccine developers, regulatory authorities, policy makers, governments etc. In this review the ongoing strategies for developing COVID-19 vaccines, some vaccine candidates and their pre- and post-development challenges have been comparatively analyzed.83 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.VaccinesVaccine candidatesCoronavirusTreatmentsChallengesCOVID-19 (Disease) -- Vaccination.Thesis